Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?

By Abdel-Khalek Mohamed   Sheir Khaled   El-Baz Mahmoud   Ibrahiem El-Houssieny  

Scandinavian Journal of Urology and Nephrology, Vol. 39, Iss. 1, 2005-02 ,pp. : 49-55

Informa Healthcare

Access to resources Recommend Favorite

''BPSA,'' a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia1

By Mikolajczyk S.D.   Millar L.S.   Wang T.J.   Rittenhouse H.G.   Wolfert R.L.   Marks L.S.   Song W.   Wheeler T.M.   Slawin K.M.  

Urology, Vol. 55, Iss. 1, 2000-01 ,pp. : 41-45

Elsevier

Access to resources Recommend Favorite

Transition zone volume and transition zone ratio: predictor of uroflow response to finasteride therapy in benign prostatic hyperplasia patients

By Tewari A.   Shinohara K.   Narayan P.  

Urology, Vol. 45, Iss. 2, 1995-02 ,pp. : 258-265

Elsevier

Access to resources Recommend Favorite

Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection

By Somford D.   Vreuls W.   Jansen T.   Basten J.   Vergunst H.  

World Journal of Urology, Vol. 32, Iss. 2, 2014-04 ,pp. : 461-467

Springer Publishing Company

Access to resources Recommend Favorite

Results of transition zone biopsy in black and white men with suspected prostate cancer - racial differences in men without prostate cancer

By Fowler J.E.   Bigler S.A.   Kilambi N.K.   Land S.A.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 346-350

Elsevier

Access to resources Recommend Favorite